Get the Stockscreener App
10.53
1.33%
-0.725
Precipio Inc stock is traded at $10.53, with a volume of 2,573.
It is down -1.33% in the last 24 hours and up +58.64% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$11.26
Open:
$11.01
24h Volume:
2,573
Relative Volume:
0.24
Market Cap:
$17.19M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-3.0789
EPS:
-3.42
Net Cash Flow:
$-2.65M
1W Performance:
-0.85%
1M Performance:
+58.64%
6M Performance:
+90.77%
1Y Performance:
+91.79%
1-Day Range:
$11.00
$11.31
1-Week Range:
$10.72
$11.80
52-Week Range:
$3.90
$11.80
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
11.00 | 17.19M | 15.81M | -4.90M | -2.65M | -3.42 |
|
TMO
Thermo Fisher Scientific Inc
|
409.42 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
203.14 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.00 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.56 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.63 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
Precipio Inc Stock (PRPO) Latest News
PRPOPrecipio Announces its Q1-2025 Financial Results - Revista ADVFN
Precipio announces executive option grants tied to stock performance - MSN
Transgenomic Inc. Reports Fourth Quarter and Fiscal Year 2003 Results - ADVFN
Precipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call Transcript - MSN
Director Makes Bold Move with Major Precipio Stock Purchase - TipRanks
Precipio anticipates return to positive cash flow in Q2 or Q3 2025 amid robust margin gains and regulatory milestones - MSN
(PRPO) Proactive Strategies - news.stocktradersdaily.com
Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call Transcript - MSN
Precipio’s Earnings Call: Cautious Optimism Amid Growth - TipRanks
Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance
Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational Efficiency Amid Seasonal Challenges - GuruFocus
Precipio Inc Reports Q1 2025 Revenue of $4.9 Million and Improved Operational Efficiency - GuruFocus
Precipio Reports Strong Q1-2025 Revenue Growth - TipRanks
Earnings call transcript: Precipio’s Q1 2025 shows revenue growth and stock surge - Investing.com Nigeria
Precipio Announces its Q1-2025 Financial Results | PRPO Stock Ne - GuruFocus
Precipio Earnings Report: Cancer Diagnostics Leader Posts 43% Revenue Growth, Targets Positive Cash Flow - Stock Titan
Precipio Announces its Q1-2025 Financial Results | PRPO Stock News - GuruFocus
Precipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue Growth - Nasdaq
Precipio Announces Its Q1-2025 Financial Results - marketscreener.com
Precipio Announces its Q1-2025 Financial Results - GlobeNewswire
Precipio Announces its Q1-2025 Financial Results - GlobeNewswire Inc.
Precipio, Inc. SEC 10-Q Report - TradingView
Renaissance Technologies LLC Invests $56,000 in Precipio, Inc. (NASDAQ:PRPO) - Defense World
Precipio Schedules Q1-2025 Shareholder Update Call - TipRanks
Precipio Announces Q1-2025 Shareholder Update Call | PRPO Stock News - GuruFocus
Precipio, Inc. (NASDAQ:PRPO) Short Interest Update - Defense World
Precipio Announces Q1-2025 Shareholder Update Call - The Globe and Mail
Cancer Diagnostics Leader Precipio Sets Q1 2025 Earnings Call: How to Join Live Update - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio - Yahoo
Trading (PRPO) With Integrated Risk Controls - news.stocktradersdaily.com
Precipio Appoints CBIZ as New Auditor Following Marcum Resignation By Investing.com - Investing.com Canada
Precipio Appoints CBIZ as New Auditor Following Marcum Resignation - Investing.com Australia
When (PRPO) Moves Investors should Listen - news.stocktradersdaily.com
Precipio COO Ahmed Zaki Sabet acquires shares worth $473 By Investing.com - Investing.com India
Precipio COO Ahmed Zaki Sabet acquires shares worth $473 - Investing.com
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... - Yahoo
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth Initiatives Unveiled - GuruFocus
Precipio’s Earnings Call: Growth Amid Challenges - TipRanks
Precipio Reports Positive Q4 Financial Results - TipRanks
Earnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shifts - Investing.com India
Precipio Full Year 2024 Earnings: US$2.93 loss per share (vs US$4.51 loss in FY 2023) - Yahoo
Precipio Inc. (PRPO) reports earnings - qz.com
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
May 27 '25 |
Buy |
9.80 |
101 |
990 |
38,776 |
| SANDBERG RICHARD A | Director |
May 22 '25 |
Buy |
9.33 |
500 |
4,665 |
38,675 |
| SANDBERG RICHARD A | Director |
May 21 '25 |
Buy |
9.27 |
8,035 |
74,474 |
38,175 |
| SANDBERG RICHARD A | Director |
May 20 '25 |
Buy |
8.47 |
4,251 |
36,006 |
30,140 |
| SANDBERG RICHARD A | Director |
May 19 '25 |
Buy |
8.21 |
714 |
5,862 |
25,889 |
| Sabet Ahmed Zaki | Chief Operating Officer |
Apr 02 '25 |
Buy |
6.00 |
79 |
474 |
939 |
| SANDBERG RICHARD A | Director |
Dec 13 '24 |
Buy |
5.80 |
15,000 |
87,000 |
19,525 |
| SANDBERG RICHARD A | Director |
Dec 13 '24 |
Sale |
6.20 |
12,000 |
74,400 |
4,525 |
1.13%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):